Cowell J K, Jay M, Rutland P, Hungerford J
Br J Cancer. 1987 Jun;55(6):661-4. doi: 10.1038/bjc.1987.135.
Fifty retinoblastoma families have been studied. In 41 it has been possible to determine the esterase-D phenotypes in all family members. Seven families were informative for the enzyme polymorphism and in all cases cosegregation of the retinoblastoma gene and esterase-D alleles was demonstrated, giving a lod score of 2.61. When combined with other published reports the cumulative lod score is 13.69 with no recombination in 45 meioses. In 10-15% of retinoblastoma families therefore, it is possible to offer prenatal diagnosis using the ESD protein polymorphism. The application of this test to the retinoblastoma population in the UK is limited by the low frequency of the rarer allele (0.116) and, as a result of genetic counseling, the smaller families generally associated with retinoblastoma.
对50个视网膜母细胞瘤家族进行了研究。在41个家族中,已能够确定所有家族成员的酯酶-D表型。7个家族的酶多态性具有信息性,在所有病例中均证实视网膜母细胞瘤基因与酯酶-D等位基因共分离,连锁值为2.61。与其他已发表的报告相结合,累积连锁值为13.69,在45次减数分裂中无重组。因此,在10%-15%的视网膜母细胞瘤家族中,可以利用ESD蛋白多态性进行产前诊断。该检测方法在英国视网膜母细胞瘤人群中的应用受到罕见等位基因低频(0.116)的限制,并且由于遗传咨询,视网膜母细胞瘤通常与较小的家族相关。